Cloud Computing

Pharma found it easier to fill cloud vacancies in Q2 of 2022

The proportion of pharmaceutical companies hiring for cloud related positions rose to a year-high in August 2021, with 42.7% of the companies included in our analysis recruiting for at least one such position.

As per an analysis of geographic trends, cloud jobs were the hardest to fill in the pharma industry in the Asia-Pacific region.

Powered by 

Cloud related jobs that were closed during Q2 2022 had been online for an average of 43.1 days when they were taken offline. 

This was a decrease compared to the equivalent figure a year earlier, indicating that the required skillset for these roles has become easier to find in the past year. 

Cloud is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies in the coming years. Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges.

On a regional level, these roles were hardest to fill in Asia-Pacific, with related jobs that were taken offline in Q2 2022 having been online for an average of 47.2 days. 

The next most difficult place to fill these roles was found to be North America, while Europe was in third place. 

At the opposite end of the scale, jobs were filled fastest in the Middle East and Africa, with adverts taken offline after 38 days on average.

While the pharmaceutical industry found it easier to fill these roles in the latest quarter, these companies actually found it harder to recruit cloud jobs than the wider market, with ads online for 5.1% more time on average compared to similar jobs across the entire jobs market. 

GlobalData's job analytics database tracks the daily hiring patterns of thousands of companies across the world, drawing in jobs as they're posted and tagging them with additional layers of data on everything from the seniority of each position to whether a job is linked to wider industry trends.

Go to article: Home | Medicine in outer spaceGo to article: In this issueGo to article: ContentsGo to article: CSafeAPSGo to article: AgilentGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: Allpack group agGo to article: CommentGo to article: Sandoz spin-off continues Novartis’ focus on innovationGo to article: High risk, high reward – the future of CAR-T therapy in CLLGo to article: bluebird bio bags landmark FDA approvals for gene therapiesGo to article: Covid-19 vaccine companies boosted with over 80% revenue growthGo to article: Urgent need to update Canada’s breast cancer screening guidelinesGo to article: The epidemiology of RSV changed in UK children during the pandemic Go to article: Zenatek Company Insight Go to article: BEA TechnologiesGo to article: In DepthGo to article: Medicine in outer space: drug development, manufacturing, and beyondGo to article: Oncology therapies dominate the orphan drug landscapeGo to article: How environmental factors could influence disease and drugsGo to article: Joining the dots: How gene regulatory network tools are unearthing drugsGo to article: Inflation drives pharma manufacturing focus on sustainability Go to article: What do remote assessments mean for sponsors?Go to article: CMO Moves: Regulatory catalysts for drug manufacturing-OctoberGo to article: TripletreeGo to article: In DataGo to article: Data analytics hiring levels in the pharma industry fell to a year-low in AugustGo to article: Pharma found it easier to fill cloud vacancies in Q2 of 2022Go to article: Pharma filings see a 56% increase in big data mentions since Q2 of 2021Go to article: Industrial automation hiring levels in pharma rose in August 2022Go to article: EventsGo to article: Next issue